April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Genotypic Comparison Of Patients With Simultaneous Geographic Atrophy And Choroidal Neovascularization And Patients With Each One Separately
Author Affiliations & Notes
  • Seanna R. Grob
    Ophthalmology, Shiley Eye Center, La Jolla, California
  • Xinrong Zhou
    Ophthalmology, Shiley Eye Center, La Jolla, California
  • Guy Hughes
    Ophthalmology, Shiley Eye Center, La Jolla, California
  • Yuhong Chen
    Ophthalmology, Shiley Eye Center, La Jolla, California
  • Matt Bedell
    Ophthalmology, Shiley Eye Center, La Jolla, California
  • Rachel Devadhason
    Ophthalmology, Shiley Eye Center, La Jolla, California
  • Igor Kozak
    Ophthalmology, Shiley Eye Center, La Jolla, California
  • Kang Zhang
    Ophthalmology, Shiley Eye Center, La Jolla, California
  • Footnotes
    Commercial Relationships  Seanna R. Grob, None; Xinrong Zhou, None; Guy Hughes, None; Yuhong Chen, None; Matt Bedell, None; Rachel Devadhason, None; Igor Kozak, None; Kang Zhang, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5237. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Seanna R. Grob, Xinrong Zhou, Guy Hughes, Yuhong Chen, Matt Bedell, Rachel Devadhason, Igor Kozak, Kang Zhang; Genotypic Comparison Of Patients With Simultaneous Geographic Atrophy And Choroidal Neovascularization And Patients With Each One Separately. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5237.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To investigate clinical presentation and genotypes in patients presenting with simultaneous geographic atrophy (GA) and choroidal neovascularization (CNV) and to compare the results to patients with just GA or CNV only.

 
Methods:
 

A database review was performed to determine 154 patients each with CNV only and GA only. Twenty patients with "CNV and GA" were chosen based on exam and imaging. Seven single nucleotide polymorphisms (SNPs) - rs2274700 and rs1061170 in CFH, rs1120638 in HTRA1, rs17611 in C5, rs2230199 in C3 and rs9332739 in C2 - were genotyped using the SNaPshot method. Chi-squared tests were used for analysis of genetic data.

 
Results:
 

In patients with "CNV and GA", GA progressed slowly and often preceded CNV. CNV presented as subretinal hemorrhage or fluid without hemorrhage. When CNV developed simultaneously, there was often an abrupt drop in visual acuity (VA), with average current VA of 20/200. In comparing "GA and CNV" group to GA only and CNV only, there is a trend that patients with both CNV and GA had a higher frequency of at risk alleles within the HTRA1 gene - rs11200638 (52.6%) when comparing to GA only patients (40.2%, 46.2%) or CNV only patients (42.9%, 41.9%), although statistical significance was not achieved.

 
Conclusions:
 

There are a scarcity of reports describing simultaneous GA and CNV. Clinical and genetic results support the fact that both GA and CNV fit on an AMD-disease continuum. There is a trend that patients with both CNV and GA had a higher frequency of at risk alleles at HTRA1 gene This finding may help increase our understanding of the disease processes involved in AMD. Further studies on more cases with concomitant GA and CNV are needed.

 
Keywords: age-related macular degeneration • genetics • choroid: neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×